Clinical Trial Update: Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing the efficacy and safety of sitagliptin in recently diagnosed, treatment-naive type 2 diabetes patients with inadequate glycem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (Januvia) (sitagliptin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2009-07-31